| 660008 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC |
2021-03-01 |
10.1136/jitc-2020-001259 |
Gui Shanying, O'Neill W Quinn, Teknos Theodoros N, Pan Quintin |
| 660007 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages |
2021-03-01 |
10.1136/jitc-2020-001657 |
Ou Da-Liang, Chen Chia-Wei, Hsu Chia-Lang, Chung Chih-Hung, Feng Zi-Rui, Lee Bin-Shyun, Cheng Ann-Lii, Yang Muh-Hwa, Hsu Chiun |
| 660006 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Higher postoperative plasma EV PD-L1 predicts poor survival in patients with gastric cancer |
2021-03-01 |
10.1136/jitc-2020-002218 |
Li Gaopeng, Wang Guoliang, Chi Fenqing, Jia Yuqi, Wang Xi, Mu Quankai, Qin Keru, Zhu Xiaoxia, Pang Jing, Xu Baixue, Feng Guangen, Niu Yuhu, Gong Tao, Zhang Hongwei, Dong Xiushan, Liu Ting, Ma Jinfeng, Gao Zefeng, Tao Kai, Li Feng, Xu Jun, Yu Baofeng |
| 660005 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment |
2021-03-01 |
10.1136/jitc-2020-001962 |
Koster Bas D, López González Marta, van den Hout Mari FCM, Turksma Annelies W, Sluijter Berbel JR, Molenkamp Barbara G, van Leeuwen Paul AM, Vosslamber Saskia, Scheper Rik J, van den Eertwegh Alfons JM, van den Tol M Petrousjka, Jordanova Ekaterina J, de Gruijl Tanja D |
| 660004 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape |
2021-03-01 |
10.1136/jitc-2020-001502 |
Caforio Matteo, Sorino Cristina, Caruana Ignazio, Weber Gerrit, Camera Antonio, Cifaldi Loredana, De Angelis Biagio, Del Bufalo Francesca, Vitale Alessia, Goffredo Bianca Maria, De Vito Rita, Fruci Doriana, Quintarelli Concetta, Fanciulli Maurizio, Locatelli Franco, Folgiero Valentina |
| 660003 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer |
2021-03-01 |
10.1136/jitc-2020-002022 |
Cao Xu, Li Bolei, Chen Jing, Dang Jessica, Chen Siqi, Gunes E Gulsen, Xu Bo, Tian Lei, Muend Sabina, Raoof Mustafa, Querfeld Christiane, Yu Jianhua, Rosen Steven T., Wang Yingyu, Feng Mingye |
| 660002 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score |
2021-03-01 |
10.1136/jitc-2020-002277 |
Dettorre Gino M, Dolly Saoirse, Loizidou Angela, Chester John, Jackson Amanda, Mukherjee Uma, Zambelli Alberto, Aguilar-Company Juan, Bower Mark, Sng Christopher C T, Salazar Ramon, Bertuzzi Alexia, Brunet Joan, Mesia Ricard, Sita-Lumsden Ailsa, Seguí Elia, Biello Federica, Generali Daniele, Grisanti Salvatore, Seeva Pavetha, Rizzo Gianpiero, Libertini Michela, Maconi Antonio, Moss Charlotte, Russell Beth, Harbeck Nadia, Vincenzi Bruno, Bertulli Rossella, Ottaviani Diego, Liñan Raquel, Marrari Andrea, Carmona-García M Carmen, Chopra Neha, Tondini Carlo Alberto, Mirallas Oriol, Tovazzi Valeria, Fotia Vittoria, Cruz Claudia Andrea, Saoudi-Gonzalez Nadia, Felip Eudald, Roqué Ariadna, Lee Alvin J X, Newsom-Davis Tom, García-Illescas David, Reyes Roxana, Wong Yien Ning Sophia, Ferrante Daniela, Scotti Lorenza, Marco-Hernández Javier, Ruiz-Camps Isabel, Patriarca Andrea, Rimassa Lorenza, Chiudinelli Lorenzo, Franchi Michela, Santoro Armando, Prat Aleix, Gennari Alessandra, Van Hemelrijck Mieke, Tabernero Josep, Diamantis Nikolaos, Pinato David J |
| 660001 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity |
2021-03-01 |
10.1136/jitc-2020-001536 |
Gao Aiqin, Liu Xia, Lin Wenli, Wang Jingnan, Wang Shuyun, Si Fusheng, Huang Lan, Zhao Yangjing, Sun Yuping, Peng Guangyong |
| 660000 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types |
2021-03-01 |
10.1136/jitc-2020-001792 |
Brown Landon C, Tucker Matthew D, Sedhom Ramy, Schwartz Eric B, Zhu Jason, Kao Chester, Labriola Matthew K, Gupta Rajan T, Marin Daniele, Wu Yuan, Gupta Santosh, Zhang Tian, Harrison Michael R, George Daniel J, Alva Ajjai, Antonarakis Emmanuel S, Armstrong Andrew J |
| 659999 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Considerations for treatment duration in responders to immune checkpoint inhibitors |
2021-03-01 |
10.1136/jitc-2020-001901 |
Marron Thomas U, Ryan Aideen E, Reddy Sangeetha M, Kaczanowska Sabina, Younis Rania H, Thakkar Dipti, Zhang Jiajia, Bartkowiak Todd, Howard Rachel, Anderson Kristin G, Olson Daniel, Naqash Abdul Rafeh, Patel Ravi B, Sachdev Esha, Rodriguez-Ruiz Maria E, Sheffer Michal, Church Sarah, Fuhrman Christopher, Overacre-Delgoffe Abigail, Nguyen Rosa, Florou Vaia, Thaxton Jessica E, Aggen David H, Guerriero Jennifer L |
